At GHX, we know the business of healthcare continues to evolve, driving critical changes in how data is used to advance clinical, financial and operational performance. Data show continued strong interest in making the move to value-based care, defined by the outcomes that matter to patients relative to the cost of delivering those outcomes. At the same time, many organizations say the transition to a system that rewards value, not the volume of services delivered, is moving too slowly, hampered by the silos that hold us back from collaborating effectively to deliver optimum patient care.
That’s why GHX is more committed than ever to ‘Uniting the best of healthcare.’ Building upon healthcare’s largest connected community of healthcare systems and suppliers, and our long-term focus on data and integration, I am pleased to announce our acquisition of Lumere, a leading provider of evidence-based data and analytics solutions that will enable GHX to help healthcare organizations build clinically integrated supply chains and optimize medication formulary management. GHX has taken this vital step to advance our mission of enabling better patient care and billions in savings for the healthcare community.
Lumere has invested deeply in defining the industry standard for product categorization that supports clinical research-based supply chain decisions for medical devices and pharmaceuticals, which are key to delivering quality patient care at an affordable cost.
Lumere’s clinical data and advanced machine learning-based analytics and capabilities pair well with GHX’s broad supply chain data. The acquisition will enable us to deliver even greater value to our combined customers as they seek to deliver the right care, to the right patients and at the right costs.
The Lumere acquisition also significantly extends GHX’s footprint in the pharmaceutical market, helping health systems more strategically manage the increasingly complex area of pharmacy cost and quality.
We have a tremendous opportunity to shape the future of healthcare as supply chain and clinical practice become closely integrated through access to more complete data about the products used in care delivery. Together, GHX and Lumere will provide an unmatched source of information that enables health systems to align purchasing and utilization decisions with evidence, and thereby accelerate the ability to manage risk and move to value-based care.
At GHX, we wake up each day looking for new ways to empower supply chain professionals, clinicians, hospital administrators and their suppliers to collaborate in innovative ways. It is only by enabling this level of collaboration, fueled by better data and insights, that we can deliver greater value for patients, and for the organizations and individuals upon which their care, and at times their lives, depend.